NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
November 3, 2025 — Heidelberg Pharma presents new clinical data for HDP-101 ADC showing promising anti-tumor activity in multiple myeloma patients at World ADC Congress 2025.
November 3, 2025 — American Heart Association launches initiative with Kardigan to boost aortic stenosis clinical trial participation & early diagnosis through 40+ hospitals. Learn about new treatment access.
November 3, 2025 — NanoViricides presents groundbreaking antiviral platform targeting COVID, RSV & influenza. Clinical-stage company developing broad-spectrum nanoviricide drugs to prevent viral escape.
November 3, 2025 — Sapu Nano announces first-in-human trial of Sapu-003, an injectable Everolimus for breast cancer, offering higher bioavailability and efficacy. Key partners include SOCRU and Medicilon.
November 3, 2025 — Soligenix strengthens its CTCL Medical Advisory Board to advance HyBryte™ therapy development. Clinical-stage biotech company updates expert team for cutaneous T-cell lymphoma treatment program.
November 3, 2025 — LogicMark CEO discusses company's SaaS growth strategy and innovation in personal emergency response systems. Learn how their Connected Care Platform protects at-risk populations.
November 3, 2025 — LogicMark CEO Chia-Lin Simmons discusses the company's personal emergency response systems and connected care platform for seniors and at-risk populations on Benzinga All-Access.
November 3, 2025 — GeoVax Labs relocates corporate HQ and labs to Atlanta to accelerate cancer therapies and vaccine development. Clinical-stage biotech expands in Georgia's bio-ecosystem for market readiness.
November 3, 2025 — ABVC BioPharma reports 230% revenue growth in Q3 2025, with $11M Taiwan land acquisitions for manufacturing expansion and clinical pipeline advancement in CNS and oncology.
November 3, 2025 — New research shows CPR within 5 minutes nearly doubles child survival after cardiac arrest. Study reveals children have half the time window of adults for successful intervention.
November 3, 2025 — New study shows optimal cardiovascular health reduces dementia risk in Type 2 diabetes patients, even with high genetic risk. Life's Essential 8 metrics protect brain function.
November 3, 2025 — New study reveals hidden heart dysfunction triples stroke risk in cardiac amyloidosis patients. Noninvasive tool may identify high-risk individuals for preventive treatment.
November 3, 2025 — New study links long-term melatonin use to 90% higher heart failure risk in insomnia patients. Research finds increased hospitalization and mortality with extended melatonin supplement use.
November 3, 2025 — New research shows combining 3 blood tests—lipoprotein(a), remnant cholesterol & hsCRP—identifies people with 3x higher heart attack risk. Early detection could save lives.
November 3, 2025 — Study finds low-dose aspirin reduces heart attack and stroke risk in Type 2 diabetes patients with cardiovascular risk. Research shows 42% lower heart attack rates among aspirin users.
November 3, 2025 — AI algorithm detects structural heart disease using smartwatch ECG with 88% accuracy. Yale study shows wearable tech can identify weakened heart function, valve damage in real-world testing.
November 3, 2025 — New research links artificial nighttime light exposure to increased heart disease risk through brain stress and artery inflammation. Study reveals biological pathway connecting light pollution to cardiovascular health problems.
November 3, 2025 — Dr. Carolyn Whitney earns second TOP 50 Most Distinguished Professionals in Health award from Preferred Health Magazine. Memphis pediatrician recognized for 30+ years of exceptional care.
November 3, 2025 — Over 180,000 Maryland residents face major health care premium hikes as Obamacare subsidy deadline approaches. Learn how the political impasse affects healthcare costs.
November 3, 2025 — Maryland health insurance open enrollment faces major changes: expiring tax credits, premium hikes up to 13.4%, DACA recipients barred from marketplace, and shortened future enrollment windows.